Skip to content
Search

Latest Stories

Donanemab drug shows potential in slowing Alzheimer’s progression

This antibody medicine targets a specific protein that accumulates in the brains of those with Alzheimer’s during the early stages of the disease

Donanemab drug shows potential in slowing Alzheimer’s progression

A new drug called donanemab has emerged as a potential breakthrough in the fight against Alzheimer's, following a global trial that confirms its ability to slow cognitive decline, the BBC reported.

This antibody medicine targets a specific protein that accumulates in the brains of those with Alzheimer's during the early stages of the disease.


While not a cure, the results published in the journal JAMA indicate a promising new era in Alzheimer's treatment.

The UK's drugs watchdog is currently evaluating donanemab for potential NHS use.

The drug has shown efficacy in slowing the progression of Alzheimer's disease, allowing patients to maintain more of their day-to-day activities and cognitive abilities.

However, it is essential to note that the drug is not without side effects, with brain swelling reported in some patients during the trial.

Donanemab's effects have been demonstrated in a study of 1,736 people aged 60 to 85 with early-stage Alzheimer's.

Half of the participants received a monthly infusion of the treatment, while the other half were administered a placebo over an 18-month period. The findings revealed that the drug showed meaningful benefits for some patients.

Those with earlier stages of the disease and lower baseline brain amyloid levels experienced greater benefits, as observed through brain scans showing clearance.

Additionally, the patients receiving the drug retained more of their day-to-day functioning, including the ability to discuss current events, answer the phone, and engage in hobbies.

Overall, the pace of the disease's progression was slowed by approximately 20-30%, and in a specific group of patients believed more likely to respond, the slowing was 30-40%.

However, there were significant side-effects, underscoring the importance of patients being aware of potential treatment risks.

Also, half of the patients on donanemab were able to discontinue the treatment after a year, as it had successfully cleared sufficient brain deposits.

Despite these positive findings, experts caution that amyloid is just one aspect of Alzheimer's complexity, and it remains unclear if the treatment will continue to have a significant impact over an extended period.

While the drug's impact may be modest, it provides confirmation that targeting amyloid in the brain can potentially alter the course of Alzheimer's, benefiting patients if administered at the right time.

The breakthrough findings have received accolades from experts and organizations in the field of Alzheimer's research.

Former UK prime minister David Cameron has called for further investment in research to develop a "statin for the brain," a pill that can clear harmful proteins from the brain and reduce the risk of dementia-causing diseases.

However, while donanemab and other emerging Alzheimer's drugs offer hope, challenges lie ahead in terms of NHS readiness and affordable access to treatments.

The Alzheimer's Society estimates that approximately 720,000 people in the UK could potentially benefit from these treatments once approved, but more work is needed to ensure timely and accurate diagnosis and effective implementation in the healthcare system.

More For You

Spain Slashes Airbnb Listings

The government described as a “lack of control” and growing “illegality” in the holiday rentals market

iStock

Spain Airbnb crackdown removes 65,000 tourist rentals amid housing concerns

The Spain Airbnb crackdown has led to more than 65,000 holiday rental listings being removed from the platform, as the Spanish government takes firm action to address breaches in national regulations and respond to growing housing concerns.

The Ministry of Consumer Affairs ordered the mass delisting due to thousands of properties lacking valid licence numbers, having unclear ownership records, or showing discrepancies between listed information and official housing databases. The government said these violations warranted immediate removal from Airbnb’s platform.

Keep ReadingShow less
10 stars turning nostalgia into marketing

Stars are turning memories into marketing in 2025’s most nostalgic campaigns

From Beyoncé to John Cena, 10 stars turning nostalgia into marketing gold

From 90s fashion flashbacks to revived cartoon icons, 2025 is proving that everything old is new again or at least in celebrity-fronted brand campaigns. This decade, nostalgia isn’t just a vibe, but a full-blown economy. Across fashion, gaming, beauty, and music, brands are digging into pop culture’s archives to strike an emotional chord with consumers. Whether it’s John Cena teaming up with SpongeBob SquarePants for a gaming crossover, or Beyoncé revisiting a classic Levi’s ad from 1991, the throughline is clear: audiences crave the familiar but with a fresh twist.

But why does it work? Because in a world of algorithm-chasing trends and digital fatigue, nothing hits harder than the warm, fuzzy punch of ‘remember when’. And the biggest names in entertainment, fashion, and music are cashing in big time.
Here are 10 brilliant nostalgia plays of 2025, ranked by how hard they made us yell, "Take my money!"

Keep ReadingShow less
P&O Cruises

P&O Cruises has announced that these will go on sale from 4 June 2025

P&O

P&O cancels Ventura Caribbean cruise, second long-haul trip cancelled in recent times

Passengers set to embark on a 35-night Caribbean cruise aboard P&O Cruises’ Ventura have had their plans disrupted, after the cruise was cancelled due to “operational reasons”. The voyage was scheduled to depart on 4 January 2027 and was to take travellers across multiple Caribbean destinations.

The cancellation marks the second recent long-haul voyage to be pulled by the cruise line. Earlier, a 14-night sailing on Iona, set to leave on 30 August 2026, was also cancelled, citing the same reasons.

Keep ReadingShow less
Malayali nurse invited to Buckingham Palace

Her journey reflects the challenges many international healthcare workers face

Indian Express

Malayali nurse invited to Buckingham Palace for supporting international NHS staff

A nurse from Kerala who has worked to support fellow Malayali professionals in the UK has been invited to attend King Charles III’s garden party at Buckingham Palace in recognition of her contributions to the NHS and international nursing community.

Prabin Baby, 45, who currently works as a patient experience nurse in Hertfordshire, received the invitation in acknowledgement of her efforts to help internationally trained nurses, particularly from Kerala, integrate into the British healthcare system.

Keep ReadingShow less
Megan Thee Stallion Unveils Hot Girl Summer Swimwear Line

The new collection arrives just ahead of the summer season

Getty

Megan Thee Stallion launches ‘Hot Girl Summer’ swimwear collection in time for summer

Megan Thee Stallion has unveiled her own swimwear brand, named Hot Girl Summer, marking her first foray into fashion retail with a collection that will be available both online and in stores across the United States.

The 30-year-old Grammy Award-winning rapper, born Megan Jovon Ruth Pete, announced the launch of Hot Girl Summer earlier this week. The name of the brand draws from the popular phrase she first coined and later trademarked in January 2022. The phrase became widely known in 2019, prompting widespread use by fans and major companies.

Keep ReadingShow less